BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26433890)

  • 1. Targets, Toxins, and T Cells--a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas.
    Hebb J; Kohrt H
    Curr Hematol Malig Rep; 2015 Dec; 10(4):438-47. PubMed ID: 26433890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapies in peripheral T-cell lymphomas.
    O'Leary HM; Savage KJ
    Curr Hematol Malig Rep; 2008 Oct; 3(4):213-20. PubMed ID: 20425468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral T-cell lymphoma.
    Foss FM; Zinzani PL; Vose JM; Gascoyne RD; Rosen ST; Tobinai K
    Blood; 2011 Jun; 117(25):6756-67. PubMed ID: 21493798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Tomita N; Motomura S; Hyo R; Takasaki H; Takemura S; Taguchi J; Fujisawa S; Ogawa K; Ishigatsubo Y; Takeuchi K
    Cancer; 2007 Mar; 109(6):1146-51. PubMed ID: 17311304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel targeted therapies in peripheral T cell lymphoma.
    Jagadeesh D; Smith MR
    Discov Med; 2013 Jun; 15(85):367-78. PubMed ID: 23819951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's new in peripheral T-cell lymphomas.
    Luminari S; Skrypets T
    Hematol Oncol; 2021 Jun; 39 Suppl 1(Suppl 1):52-60. PubMed ID: 34105820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and treatment of rare and aggressive types of peripheral T-cell/natural killer-cell lymphomas of the skin.
    Rezania D; Sokol L; Cualing HD
    Cancer Control; 2007 Apr; 14(2):112-23. PubMed ID: 17387296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antibody approaches to lymphoma therapy.
    Suresh T; Lee LX; Joshi J; Barta SK
    J Hematol Oncol; 2014 Sep; 7():58. PubMed ID: 25355407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of advanced-stage peripheral T-cell lymphomas.
    Kimby E
    Curr Hematol Malig Rep; 2007 Oct; 2(4):242-8. PubMed ID: 20425376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: peripheral T-cell lymphomas.
    Savage KJ
    Curr Hematol Malig Rep; 2011 Dec; 6(4):222-30. PubMed ID: 21953415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for peripheral T-cell lymphomas.
    Foss FM
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):43-56. PubMed ID: 23768640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTCL therapies: a review of treatment and outline of novel therapies.
    Khan N; Cheson BD
    Am J Ther; 2013; 20(5):524-33. PubMed ID: 23528371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study.
    Kim JG; Sohn SK; Chae YS; Cho YY; Yang DH; Lee JJ; Kim HJ; Shin HJ; Chung JS; Cho GJ; Lee WS; Joo YD; Sohn CH; Oh SJ
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):129-34. PubMed ID: 17406867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New molecular insights into peripheral T cell lymphomas.
    Pileri SA; Piccaluga PP
    J Clin Invest; 2012 Oct; 122(10):3448-55. PubMed ID: 23023716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T time: Emerging and new therapies for peripheral T-cell lymphoma.
    Mina A; Pro B
    Blood Rev; 2022 Mar; 52():100889. PubMed ID: 34716031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leu-22 (L60). A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell types.
    Macon WR; Casey TT; Kinney MC; Collins RD; Cousar JB
    Am J Clin Pathol; 1991 May; 95(5):696-701. PubMed ID: 1827236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
    Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted treatment and new agents in peripheral T-cell lymphoma.
    Zain JM; O'Connor O
    Int J Hematol; 2010 Jul; 92(1):33-44. PubMed ID: 20535594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.